The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children with poor survival. New treatment approaches are urgently needed to improve treatment efficacy in RMS patients. DMAMCL is a novel agent...

Source: Journal of Experimental and Clinical Cancer Research - March 8, 2019 Category: Cancer & Oncology Authors: Ning Xu, Zhongyan Hua, Gen Ba, Simeng Zhang, Zhihui Liu, Carol J. Thiele and Zhijie Li Tags: Research Source Type: research